Live Breaking News & Updates on Translational Research Initiative

Stay updated with breaking news from Translational research initiative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

"Optimizing the bioinks for islet tissue engineering by using a customi" by Narangerel Gantumur

Type-1 diabetes (T1D) is a chronic metabolic autoimmune disease where the patient's immune system destroys insulin-producing β-cells in the islet of Langerhans. The current treatment option is through frequent administration of exogenous insulin, where the patients must closely monitor the dosage. Patients often need islet transplantation when the β-cell destruction worsens, and the body cannot utilize exogenously administrated insulin. Islet transplantation is a form of cell therapy that could restore endogenous insulin production. However, this method has several drawbacks, including low survival of functional islets and allograft tissue immunogenicity. A recently emerging tissue engineering approach can offer a possible solution to address the limitations of islet transplantation. A 3D structure fabricated by simultaneously printing various cell types could improve the survival and function of islet grafts by providing revascularization and immune protection.
This project ....

Translational Research Initiative For Cell Engineering , Dual Ink Co Axial Bioprinter , Translational Research Initiative , Cell Engineering , 3d Bioprinting , Islet Transplantation , Ioink Development ,

Sydney, New South Wales showcase medtech, biotechnology, health infrastructure at Expo 2020 Dubai

NSW is home to 4 of Australia’s top 10 universities, many of whom feature in the top 100 universities in the world and is also home to 37 per cent of the Australia’s. ....

Ministry Of Health , United Arab Emirates , New South Wales , United Kingdom , Stephen Cartwright , John Cavanagh , Samir Moosani , Ramadan Al Blooshi , Justin Mcgowan , Ian Halliday , Marwan Al Mulla , Jasin Thaj , Yasmine Choualhi , Amin Al Amiri , Moin Anwar , Patricia Davidson , Abdulkareem Al Olama , Saleh Al Hashimi , Al Jalila Foundation , Dubai Health Authority , University Of Wollongong , Dubai Health Insurance Corporation , European Union , Translational Research Initiative For Cell Engineering , Undersecretary Of Health Regulation , Health Regulation Sector ,

Innovative health

The Australian state of New South Wales (NSW), home to the city of Sydney, highlighted its world-class health, medtech and R&D ecosystem at a VIP dinner event held at the Australia Pavilion at Expo 2020 Dubai. ....

United Arab Emirates , New South Wales , United Kingdom , Ministry Of Health , Stephen Cartwright , Ramadan Al Blooshi , Ian Halliday , Edward Lorenz , Michelle Lau , Marwan Al Mulla , Amin Al Amiri , Moin Anwar , Patricia Davidson , Abdulkareem Al Olama , Saleh Al Hashimi , Al Jalila Foundation , Dubai Health Authority , University Of Wollongong , Dubai Health Insurance Corporation , European Union , Translational Research Initiative For Cell Engineering , Undersecretary Of Health Regulation , Health Regulation Sector , Australia Pavilion , Major Partner , Australian Pavilion ,

UOW partners with University of British Columbia to treat spinal cord injury

The multidisciplinary team will develop a biomaterial bridge to help regrow nerve fibres in the spine Spinal cord injury (SCI) is damage to the spinal ....

United States , United Kingdom , John Madden , Gordon Wallace , Canadian University Of British Columbia , Centre Of Excellence , University Of Wollongong , World Health Organisation , University Of British Columbia , Translational Research Initiative For Cell Engineering , Canada New Frontiers In Research Fund , British Columbia , Canadian University , New Frontiers , Research Fund , Electromaterials Science , Principal Investigator , Translational Research Initiative , Cell Engineering ,

Investigational magnetic device shrinks glioblastoma in first-in-world human test

Investigational magnetic device shrinks glioblastoma in first-in-world human test
Houston Methodist Neurological Institute researchers from the department of neurosurgery shrunk a deadly glioblastoma tumor by more than a third using a helmet generating a noninvasive oscillating magnetic field that the patient wore on his head while administering the therapy in his own home. The 53-year-old patient died from an unrelated injury about a month into the treatment, but during that short time, 31% of the tumor mass disappeared. The autopsy of his brain confirmed the rapid response to the treatment.
“Thanks to the courage of this patient and his family, we were able to test and verify the potential effectiveness of the first noninvasive therapy for glioblastoma in the world,” said David S. Baskin, M.D., FACS, FAANS, corresponding author and director of the Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment in the Department of Neurosurgery at Houston Methodist. ....

Santosh Helekar , Elisa Nguyen , Martyna Sharpe , Davids Baskin , Marlee Swarz Foundation , Houston Methodist Research Institute Institutional Review Board , Department Of Neurosurgery At Houston Methodist , Kennethr Peak Center , Johns Dunn Foundation , Taub Foundation , Methodist Hospital Foundation , Kelly Kicking Center Foundation , Veralan Foundation , Access Program , Kennethr Peak Foundation , Pituitary Tumor Treatment , Oncology Baskin , Oncomagnetic Device , Expanded Access Program , Peak Clinic , End Stage Recurrent Glioblastoma Treated , New Noninvasive Non Contact Oncomagnetic Device , Translational Research Initiative , Houston Methodist Research Institute , Kenneth Peak , Blanche Green Fund ,